Patent · US Active

Treating disease and promoting weight loss by inhibiting the TMA/FMO3/TMAO pathway

US11771659B2 · kind B2 · utility

0Cited by

9References

20Claims

0Family size

Assignee

The Cleveland Clinic Foundation · US

Inventors

Stanley L. Hazen · Pepper Pike, US
Jonathan Brown · Cleveland, US

Key dates

Filing date	Jun 19, 2018
Grant date	Oct 3, 2023
Priority date	—
Expiry date	Nov 3, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions, systems, and methods for causing weight loss and treating and/or preventing a disease or condition, such as obesity, diabetes, and cancer, with an agent or procedure that inhibits the TMA/FMO3/TMAO pathway in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.